ES483661A1 - Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos - Google Patents

Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos

Info

Publication number
ES483661A1
ES483661A1 ES483661A ES483661A ES483661A1 ES 483661 A1 ES483661 A1 ES 483661A1 ES 483661 A ES483661 A ES 483661A ES 483661 A ES483661 A ES 483661A ES 483661 A1 ES483661 A1 ES 483661A1
Authority
ES
Spain
Prior art keywords
preparation
sila
substituted
processes
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES483661A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES483661A1 publication Critical patent/ES483661A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Los nuevos derivados de 1,4-dihidropiridina sila-sustituidos se pueden transformar en forma conocida en las formulaciones usuales tales como tabletas, cápsulas, grageas, píldoras, granulados, aerosoles, jarabes, emulsiones, suspensiones o soluciones empleando excipientes o disolventes inertes, no tóxicos, farmacéuticamente adecuados. Aquí deberá encontrarse el compuesto terapéuticamente activo, en cada caso presente en una concentración de aproximadamente de unos 0,5 hasta 90% en peso de la mezcla total, es decir, en cantidades que sean suficientes para alcanzar el margen de dosificación indicado. Las formulaciones se preparan, por ejemplo, mediante alargamiento de las sustancias activas con disolventes y/o excipientes, en caso dado empleando emulsionantes y/o agentes de dispersión donde, por ejemplo, en el caso de emplear agua como diluyente se pueden emplear en caso dado disolventes orgánicos como disolventes auxiliares.
ES483661A 1978-08-28 1979-08-27 Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos Expired ES483661A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782837477 DE2837477A1 (de) 1978-08-28 1978-08-28 Sila-substituierte 1,4-dihydropyridin- derivate

Publications (1)

Publication Number Publication Date
ES483661A1 true ES483661A1 (es) 1980-04-16

Family

ID=6048072

Family Applications (1)

Application Number Title Priority Date Filing Date
ES483661A Expired ES483661A1 (es) 1978-08-28 1979-08-27 Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos

Country Status (8)

Country Link
US (1) US4237137A (es)
EP (1) EP0010130B1 (es)
JP (1) JPS5533497A (es)
AT (1) ATE489T1 (es)
CA (1) CA1135699A (es)
DE (2) DE2837477A1 (es)
ES (1) ES483661A1 (es)
IL (1) IL58103A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2915355A1 (de) * 1979-04-14 1980-10-23 Nattermann A & Cie Neue 1,4-dihydropyridin-bderivate mit antihypertensiver wirkung
US4325389A (en) * 1980-09-22 1982-04-20 Cordis Corporation Tip assembly for a carbon fiber implantable lead
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE3433239A1 (de) * 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung
US4593033A (en) * 1985-04-24 1986-06-03 Merck & Co., Inc. Substituted indeno[2,1-c] pyridines useful as calcium channel blockers
US4605660A (en) * 1985-06-03 1986-08-12 Merck & Co., Inc. Indeno[2,1-c]pyridine compounds, and their use as calcium channel blockers
US4670443A (en) * 1985-07-02 1987-06-02 Merck & Co., Inc. Benzo(f)isoquinoline compounds useful as calcium entry blockers
US4735956A (en) * 1985-09-13 1988-04-05 Merck & Co., Inc. Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers
EP0220917B1 (en) * 1985-10-22 1991-01-30 Sanwa Kagaku Kenkyusho Co., Ltd. 1,4-dihydropyridine pharmaceutical derivatives and their salts, and the preparation thereof
US4721708A (en) * 1985-11-26 1988-01-26 Merck & Co., Inc. Cyclized N-substituted-tetrahydropyridine compounds and cardiovascular use
US4788203A (en) * 1985-11-26 1988-11-29 Merck & Co., Inc. Cyclized N-substituted-tetrahydropyridine compounds, useful in the treatment of cardiovascular disorders
US4841054A (en) * 1986-10-21 1989-06-20 Lukevits Edmund Y 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(5'-trimethylsilyl-2'-furyl)-1,4-dihydropyridine
DE102005056050A1 (de) * 2005-11-24 2007-05-31 Wacker Chemie Ag Alpha-(beta-Ketocarbonyl)-funktionelle Organosiliciumverbindungen und deren Herstellung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3355455A (en) * 1964-08-06 1967-11-28 Dow Corning Certain pyridyl silane derivatives
US3816439A (en) * 1970-06-19 1974-06-11 Monsanto Co Substituted 1,2-dihydropyridines and process for preparing same
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3781291A (en) * 1971-05-26 1973-12-25 R Sulzbach Silylated 1,4-dihydropyridines
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
DE2248150A1 (de) * 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
IL58103A0 (en) 1979-12-30
DE2961609D1 (en) 1982-02-11
JPS5533497A (en) 1980-03-08
IL58103A (en) 1983-06-15
EP0010130B1 (de) 1981-12-23
US4237137A (en) 1980-12-02
CA1135699A (en) 1982-11-16
ATE489T1 (de) 1982-01-15
JPS6217595B2 (es) 1987-04-18
DE2837477A1 (de) 1980-03-13
EP0010130A1 (de) 1980-04-30

Similar Documents

Publication Publication Date Title
ES485540A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas, congrupos ester funcionalizados
DE3166441D1 (en) Novel antihistamines, process for their preparation and pharmaceutical compositions containing them
ES8104228A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas op- ticamente activas
IL58775A0 (en) Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them
ES468525A1 (es) Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
ES475633A1 (es) Procedimiento para la obtencion de derivados de 1-n-4,6-di-0-(aminoglicosil)-1,3-diamino-ciclitol.
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
PT66089A (en) Process for preparing 1,2-benzisothiazolin-3-ona with anti-thrombotic effect,application of same for the preparation of pharmaceutical compositions with anti-thrombic effect and application of these pharmaceutical compositions for the treatment of thrombosis
ES478048A1 (es) Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos.
PT71408A (de) Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
PT71308A (en) Process for the preparation of new 3,4,5-trihidrocy-piperidine derivatives with pharmaceutical and/or veterinary effect
NL8301963A (nl) Nieuwe derivaten van 4-hydroxychinoline-3-carbonzuur die op de 2-plaats zijn gesubstitueerd, werkwijzen voor hun bereiding, hun toepassing als geneesmiddel en preparaten die ze bevatten en de verkregen tussenprodukten.
IL61989A (en) 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them
ES473316A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas.
ES462387A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridin-azucar.
DE3060669D1 (en) Phenylalanyl-tryptophan derivatives, pharmaceutical compositions containing them, their preparation and use
DE2964803D1 (en) 2-azaergolines and 2-aza-8(or 9)-ergolenes, process for their preparation and pharmaceutical compositions containing them
ES8504166A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz(b,e) oxepina.
ES8200871A1 (es) Procedimiento para la obtencion de derivados de 2-amino-3,4-dihidropiridina
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
ES472771A1 (es) Procedimiento para la obtencion de 2-piridin-1,4-dihidropi- ridinas
DE3879709T2 (de) Platin-arzneimittel.